Hyponatremia
Hyponatremia
Hyponatremia is a low blood sodium condition that reflects a water–sodium imbalance. This category helps you compare therapies used in specific clinical settings and drugs linked to risk. It also points to related conditions and supportive products. Options here are suitable for research, education, and supervised care planning, with US shipping from Canada. You can browse tablets and dosing strengths, review contributing medicines, and see alternatives by indication. Inventory and strengths may vary over time, and listings can change without notice. People often search for hyponatremia symptoms, typical lab cutoffs, and how treatments differ by fluid status.Hyponatremia OverviewClinically, hyponatremia means serum sodium below 135 mmol/L. Mild cases may be subtle; moderate levels can cause headache, nausea, or confusion. Rapid onset increases risk of cerebral edema. Very low values raise seizure and herniation risk. The mechanism involves excess water relative to sodium, often mediated by antidiuretic hormone. Common hyponatremia causes include medications, endocrine disorders, cardiac or hepatic congestion, and primary polydipsia. Classifying volume status—hypovolemic, euvolemic, or hypervolemic—guides the plan. Rate of onset and chronicity also matter for safe correction.Diagnosis merges clinical context with labs such as serum osmolality, urine sodium, and urine osmolality. Imaging or endocrine tests may be needed when the story is unclear. Management focuses on the underlying driver and careful sodium correction. Overly rapid shifts can cause osmotic demyelination, especially in malnutrition or alcoholism. Clinicians may cap daily correction and reassess frequently. Related pages and therapies below can help you navigate medication classes involved in this condition.What’s in This CategoryThis section includes agents used in selected cases and medicines commonly associated with dilutional sodium changes. V2 receptor antagonists support water clearance in euvolemic or hypervolemic cases under specialist oversight. Loop and thiazide diuretics appear because fluid balance strategies often intersect with sodium disorders. Some anticonvulsants and antidepressants are listed due to their SIADH risk. You can review labels, tablet strengths, and typical starting doses where provided. Content here does not replace prescriber judgment.Examples include loop diuretics like Furosemide and thiazides such as Hydrochlorothiazide. Combination options like Spironolactone-HCTZ appear with cautions about sodium monitoring. Selected anticonvulsants—including Carbamazepine and Oxcarbazepine—are present due to recognized SIADH associations. You can also explore targeted agents used in hyponatremia treatment under specialist care. Stock, brands, and quantities may change without notice.How to ChooseSelection starts with the precise subtype and cause. Assess hypovolemic, euvolemic, or hypervolemic states, and whether onset was acute or chronic. Document baseline risks for osmotic demyelination and comorbid liver disease. Consider drug interactions, particularly CYP3A effects with certain aquaretics. Always align the correction target and monitoring plan with hyponatremia levels and clinical trajectory. When medications contribute, dose reduction or substitution may be safer than adding more drugs.Use practical criteria to compare options:Match class to volume status and underlying condition.Check hepatic, renal, and electrolyte monitoring requirements.Review maximum duration limits and black box warnings.Confirm tablet strengths and titration steps align with protocols.Plan rescue strategies if sodium rises too quickly.In some protocols, loop diuretics may assist free water clearance alongside salt and fluid strategies. Conversely, thiazides may worsen dilutional states in susceptible patients. Anticonvulsants and antidepressants can trigger SIADH; deprescribing or switching may be advised. Products here help you understand labeling and class roles before discussing a plan with your clinician.Popular OptionsOne representative option is Samsca (tolvaptan), a selective V2 receptor antagonist. It promotes aquaresis in euvolemic or hypervolemic settings and requires close monitoring. Labeling limits duration and highlights liver safety considerations. Another common tool is Furosemide, often used to aid water removal while balancing hemodynamics. It fits best when congestion and excess volume complicate sodium status.In select protocols, Desmopressin can help control overly rapid correction by modulating antidiuretic effect. This same agent treats diabetes insipidus, so context is essential. These examples illustrate how therapies differ by indication, risk, and monitoring needs. For severe hyponatremia, inpatient care, frequent labs, and stepwise adjustments are typical. Product pages provide dosage forms and strengths, but clinical oversight determines use and duration.Related Conditions & UsesMany cases relate to endocrine or cardiorenal triggers. Inappropriate antidiuretic hormone secretion (SIADH) often causes a euvolemic pattern. Congestive states such as Heart Failure or advanced cirrhosis change water handling and sodium concentration. Chronic kidney pathology can also affect dilution and excretion. When medications drive the picture, switching classes can mitigate risk. Hypertonic strategies and monitoring schedules remain institution-specific.Other water balance disorders cross over with hyponatremia education. Central and nephrogenic variants appear in our Diabetes Insipidus resource, which explains differential diagnosis and therapy roles. Neurologic symptoms, fall risk, and medication burden influence plans in older adults. Clinicians frequently follow a structured treatment of hyponatremia according to validated pathways. Use these linked condition pages and product listings to compare options, read labels, and discuss individualized next steps with your care team.Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice.Authoritative SourcesClinical overview of causes, classification, and risks: StatPearls Hyponatremia review (NIH/NCBI).Labeling and safety information for a V2 antagonist: FDA Samsca (tolvaptan) prescribing information.Guideline discussion of diagnosis and management pathways: European Hyponatremia Practice Guideline (NDT Journal).
Filter
Product price
Product categories
Conditions
Select options
This product has multiple variants. The options may be chosen on the product page
Frequently Asked Questions
Related Articles
Endocrine & Thyroid
Central Diabetes Insipidus: Neurogenic Guide to Causes and Care
Central diabetes insipidus is a water-balance disorder caused by reduced vasopressin (antidiuretic hormone) signaling. People pass large volumes of dilute urine and feel constantly thirsty. This guide explains causes, testing,…
Endocrine & Thyroid,
Nephrogenic Diabetes Insipidus: Diagnosis and Treatment Guide
Patients with suspected nephrogenic diabetes insipidus often present with persistent thirst and large urine volumes. This guide explains how to recognize the disorder, differentiate it from central forms, and plan…
Diabetes, Type 2
Chlorpropamide Guide: Diabinese Side Effects and Dosage
This overview explains how chlorpropamide works, when it is used, and how to take it safely. It also reviews major risks, monitoring steps, and practical counseling points for everyday use.…
Endocrine & Thyroid
Diabetes Insipidus Guide: Signs, Symptoms, Treatment
Key TakeawaysCore features: excessive urination and intense thirst from impaired water balance.Confirm the cause with clinical history, labs, and targeted water testing.Treatment depends on type; plans focus on hydration and…